{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:48:24Z","timestamp":1760244504487,"version":"build-2065373602"},"reference-count":17,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Photodynamic therapy (PDT) treatment for multiple actinic keratosis (AK) has been found effective when lower doses of red light were used with methyl aminolaevulinic acid (MAL). The aim of this study was to compare the results of lower doses of red light conventional PDT (h-PDT, 16 J\/cm2) with MAL and aminolaevulinic acid (ALA) in a long-term follow-up. Patients with more than five symmetrical AK on the scalp who were candidates for PDT were selected and divided randomly between MAL and ALA treatment and patients were followed at 3 and 12 months. The responses were assessed by counting the total AK and the AK per patient. Pain and adverse events were also compiled. A total of 46 patients were treated, 24 with MAL, and 22 with ALA. The two groups were comparable at baseline (p &gt; 0.005). No significant differences were found in the results of both treatments at 12 months, despite ALA exhibiting slightly better results at 3 months. No differences in pain and adverse events were assessed. Both ALA and MAL were effective when lower doses of red light were used in c-PDT. Long term efficacy was also documented. Further studies are necessary to determine the inferior point of red-light illumination without losing efficacy.<\/jats:p>","DOI":"10.3390\/biomedicines10123218","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T04:05:22Z","timestamp":1670817922000},"page":"3218","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up"],"prefix":"10.3390","volume":"10","author":[{"given":"Montserrat","family":"Fern\u00e1ndez Guarino","sequence":"first","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, Instituto de Investigaci\u00f3n Sanitaria Irycis, 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Fern\u00e1ndez-Nieto","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, Instituto de Investigaci\u00f3n Sanitaria Irycis, 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Vila","family":"Montes","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, Instituto de Investigaci\u00f3n Sanitaria Irycis, 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-5964","authenticated-orcid":false,"given":"Dario de Perosanz","family":"Lobo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, Instituto de Investigaci\u00f3n Sanitaria Irycis, 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0190-9622(00)90209-3","article-title":"Photodynamic therapy in dermatology","volume":"42","author":"Kalka","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","first-page":"340","article-title":"Photodynamic therapy in dermatology","volume":"16","author":"Babilas","year":"2006","journal-title":"Eur. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: Treatment delivery and current indications-actinic keratoses, Bowen\u2019s disease, basal cell carcinoma","volume":"27","author":"Morton","year":"2013","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_4","first-page":"2354","article-title":"Daylight photodynamic therapy with methylaminolevulinate cream is effective and nearly painless in treating actinic keratosis: A randomized, investigator-blinded, controlled, phase III study throughout Europe","volume":"29","author":"Lacour","year":"2015","journal-title":"J. Eur. Acad. Derm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jdv.15566","article-title":"Split-face study comparing conventional MAL photodynamic therapy in multiple actinic keratosis with complete time vs. half-time red light LED conventional illumination","volume":"33","year":"2019","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2340\/00015555-2278","article-title":"Laser-mediated photodynamic therapy: An alternative Teratment for Actinic Keratosis","volume":"96","author":"Kessels","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"ref_7","first-page":"76","article-title":"The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: A randomized, controlled, noninferiority clinical study","volume":"182","author":"Mordon","year":"2020","journal-title":"Br. J. Derm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/bjd.15098","article-title":"Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: A randomized controlled trial","volume":"176","author":"Nissen","year":"2017","journal-title":"Br. J. Derm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jphotobiol.2017.07.018","article-title":"Photodynamic therapy for actinic keratosis: Is the European consensus protocol for daylight PDT superior to conventional protocol for Aktilite CL 128 PDT?","volume":"174","author":"Baert","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/lsm.22827","article-title":"Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?","volume":"50","author":"Baert","year":"2018","journal-title":"Lasers Surg. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/php.13350","article-title":"Painless Photodynamic Therapy Triggers Innate and Adaptive Immune Responses in a Murine Model of UV-induced Squamous Skin Pre-cancer","volume":"97","author":"Anand","year":"2021","journal-title":"Photochem. Photobiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jung, A.C., Moinard-Butot, F., Thibaudeau, C., Gasser, G., and Gaiddon, C. (2021). Antitumor Immune Response Triggered by Metal-Based Photosensitizers for Photodynamic Therapy: Where Are We?. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111788"},{"key":"ref_13","first-page":"41","article-title":"Low-level laser (light) therapy (LLLT) in skin: Stimulating, healing, restoring","volume":"32","author":"Avci","year":"2013","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.13076","article-title":"Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy","volume":"29","author":"Fargnoli","year":"2015","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pdpdt.2019.05.031","article-title":"Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial","volume":"27","author":"Pellegrini","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000349992","article-title":"Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis","volume":"226","author":"Gholam","year":"2013","journal-title":"Dermatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jdv.14613","article-title":"Conventional vs daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-months follow-up results of a randomized, intra-individual comparative analysis","volume":"32","author":"Sotiriou","year":"2018","journal-title":"J. Eur. Acad. Dermatol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3218\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:39:34Z","timestamp":1760146774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biomedicines10123218"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10123218","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}